Evidence map›Paper›PMID 39202029›Full record

ArticleJournal of personalized medicine2024

Impact of Vaginal Dilator Use and 68 Gy EQD2

Faegheh Noorian, Rosa Abellana, Yaowen Zhang, Antonio Herreros, Valentina Lancellotta, Luca Tagliaferri, Sebastià Sabater, Aureli Torne, Eduard Agusti-Camprubi, Angeles Rovirosa

Abstract read
In one paragraph

Article in Journal of personalized medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. D90 and DCancers · 2026
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Faegheh NoorianFonaments Clínics Department, Universitat de Barcelona, 08036 Barcelona, Spain.ORCID 0000-0002-7970-876X
Rosa AbellanaFonaments Clínics Department, Universitat de Barcelona, 08036 Barcelona, Spain.
Yaowen ZhangCancer Center, Henan Provincial People's Hospital, No.7 Weiwu Road, Zhengzhou 450003, China.
Antonio HerrerosFonaments Clínics Department, Universitat de Barcelona, 08036 Barcelona, Spain.ORCID 0000-0001-9867-481X
Valentina LancellottaDipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Policlinic Universitario Gemelli, 00168 Rome, Italy.ORCID 0000-0003-3507-7051
Luca TagliaferriDipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Policlinic Universitario Gemelli, 00168 Rome, Italy.ORCID 0000-0003-2308-0982
Sebastià SabaterRadiation Oncology Department, Hospital General Universitario de Albacete, 02006 Albacete, Spain.ORCID 0000-0003-0111-9540
Aureli TorneGynaecological Cancer Unit, Hospital Clinic, Universitat de Barcelona, 08036 Barcelona, Spain.ORCID 0000-0003-4700-9507
Eduard Agusti-CamprubiRadiological Protection Department, Hospital Clinic, Universitat de Barcelona, 08036 Barcelona, Spain.
Angeles RovirosaFonaments Clínics Department, Universitat de Barcelona, 08036 Barcelona, Spain.ORCID 0000-0002-7832-334X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study evaluated the clinical outcomes of applying a 68 Gy EQD2 MATERIAL AND

methodsWe analyzed 131 patients treated with vaginal-cuff brachytherapy after external beam irradiation. Group-1 (65 patients) received one fraction of 7 Gy, and Group-2 (66 patients) received one fraction of between 5.5 and 7.0 Gy after applying a 68 Gy EQD2

resultsWith a median follow-up of 60 months, the vaginal-cuff relapse rate was 1/131 (0.8%). Late vaginal complications appeared in 36/65 (55.4%) Group-1 patients and 17/66 (25.8%) Group-2 patients (

conclusionsA 68 Gy EQD2

Indexed as

brachytherapy schedulescomplicationsendometrial cancer

Identifiers

PMID39202029
PMCPMC11355937

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.